Narayana Hrudayalaya Limited has scheduled group meetings with analysts and institutional investors on June 10 and June 11, 2026. The meetings are organized by Choice Equity Broking Pvt. Ltd. and Macquarie Capital Securities (India) Private Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. These interactions aim to engage with key market participants to discuss the company's performance and outlook.

The first meeting is a virtual session scheduled for Wednesday, June 10, 2026, at 12:00 Noon. Participants include ASK Mutual Fund, Bajaj AMC, Bandhan Mutual Fund, BOI AXA Mutual Fund, Canara Robeco Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, JMFL Mutual Fund, Helios Mutual Fund, InCred AMC, Invesco Mutual Fund, ITI Mutual Fund, Motilal PO, Nippon Mutual Fund, and Taurus Mutual Fund.

The following table details the institutions scheduled to participate in the virtual meeting:

A separate physical meeting is set to take place on June 11, 2026, at 04:00 P.M. (IST). Participants for this session include Julius Baer Capital (India) Private Limited, Lion Global Fund from Singapore, Ninety-One from London, Quantum Asset Management Company Pvt Ltd, and TATA AIG General Insurance Company Limited. Additional attendees such as Whiteoak Mutual Fund, Bajaj Allianz Life Insurance, IndusInd Insurance, PNB MetLife Insurance, Shriram Life Insurance, Star Union Dai-ichi Life Insurance, and Universal Sompo General Insurance are also tentatively scheduled.

The company has stated that the investor lists and meeting schedules are tentative. Changes may occur due to the availability of the investors or other unforeseen circumstances on the part of the analysts, investors, and the company. The disclosures were submitted to the stock exchanges on June 05, 2026.

Narayana Hrudayalaya Limited has released the transcript of its earnings call for the quarter and financial year ended March 31, 2026. The call, held on May 26, 2026, featured management discussing financial results, operational efficiencies, and strategic initiatives across its India, Cayman Islands, and UK businesses. The transcript is now available on the company's stakeholder relations website, providing detailed insights into the company's performance and future outlook.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Sridhar S., Group Company Secretary, Legal & Compliance Officer.

Key Operational Updates

During the call, management highlighted significant progress in high-end medical procedures, particularly in the Bangalore cluster. The facility performs approximately 100 robotic cardiac surgeries per month and around 160 percutaneous aortic valve reimplantation procedures. The company emphasized that the complexity of cases delivered in Bangalore has driven financial gains, with the hospital business in India seeing margins expand to 25.1% in Q4FY26 from 21.5% in the same quarter of the previous year.

Strategic Guidance and Expansion

Management addressed questions regarding the company's integrated care model, specifically the role of pharmacies and clinics. Viren Shetty, Vice Chairman, clarified that all pharmacies within hospitals and clinics are part of the listed entity's P&L and serve internal demand rather than operating as a standalone retail vertical. The company plans to expand its clinic footprint, aiming to double the current number of clinics, including expansion into Kolkata in FY27.

Financial Performance and Outlook

The company provided updates on its international acquisitions. For the UK business, acquired in the previous year, management noted that while margins have shown improvement, a few more quarters are needed to fully baseline costs and provide consistent commentary. The GBP 150 million loan taken for the acquisition is being serviced locally in the UK, mitigating currency risk. In the Cayman Islands, the insurance business is experiencing losses due to a faster-than-anticipated ramp-up, with price increases expected to improve the loss ratio over the next three quarters.

Call Details

The transcript can be accessed via the stakeholder relations section of the Narayana Hrudayalaya website.